Eric D Esparbes Biora Therapeutics, Inc. (BIOR) insider trading activity

Eric D Esparbes is Chief Financial Officer of BIORA THERAPEUTICS, INC.. Currently has a direct ownership of 575,832 shares of BIOR, which is worth approximately $270,641. The most recent transaction as insider was on Aug 15, 2024, when has been sold 27,830 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $18,646. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 576K

0% 3M change

875.79% 12M change

Total Value Held $270,641

Eric dEsparbes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2024	SELL Payment of exercise price or tax liability	$18,646 $0.67 p/Share	27,830 Reduced 4.61%	575,832 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	325,000 Added 35.0%	603,662 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$125,669 $3.14 p/Share	40,022 Reduced 40.41%	59,012 Common Stock
Aug 15 2023	BUY Grant, award, or other acquisition	-	219,650 Added 44.08%	278,662 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$9,403 $3.35 p/Share	2,807 Reduced 2.76%	99,034 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$28,712 $2.56 p/Share	11,216 Reduced 9.92%	101,841 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	84,917 Added 42.89%	113,057 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$930 $3.46 p/Share	269 Reduced 0.95%	28,140 Common Stock
Jan 03 2023	SELL Sale (or disposition) back to the issuer	-	95 Reduced 100.0%	0 Series X Preferred Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$1,402 $0.27 p/Share	5,194 Reduced 0.73%	710,122 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$6,190 $1.04 p/Share	5,952 Reduced 0.83%	708,429 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$7,790 $0.75 p/Share	10,387 Reduced 2.45%	412,784 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	292,406 Added 29.31%	705,190 Common Stock
Apr 15 2022	BUY Grant, award, or other acquisition	-	231,693 Added 35.38%	423,171 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$9,346 $1.9 p/Share	4,919 Reduced 2.5%	191,478 Common Stock
Aug 15 2021	SELL Payment of exercise price or tax liability	$9,492 $1.66 p/Share	5,718 Reduced 2.83%	196,397 Common Stock
Apr 15 2021	SELL Payment of exercise price or tax liability	$46,683 $3.41 p/Share	13,690 Reduced 6.34%	202,115 Common Stock
Apr 15 2021	BUY Grant, award, or other acquisition	-	123,382 Added 36.38%	215,805 Common Stock
Mar 04 2021	SELL Payment of exercise price or tax liability	$6,512 $4.05 p/Share	1,608 Reduced 1.71%	92,423 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$30,022 $5.6 p/Share	5,361 Reduced 5.39%	94,031 Common Stock
Dec 19 2020	SELL Payment of exercise price or tax liability	$7,761 $6.32 p/Share	1,228 Reduced 1.22%	99,392 Common Stock

Eric D Esparbes

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIOR shares.

Notify only if

Value

Insider Trading

Get notified when an Biora Therapeutics, Inc. insider buys or sells BIOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIORA THERAPEUTICS, INC.

Track Activities on BIOR

Account